Abeona Therapeutics CCO Sells 222 Shares for Tax Withholding

This Form 4 filing reports that Madhav Vasanthavada, Chief Commercial Officer of Abeona Therapeutics Inc. (ABEO), disposed of 222 shares of common stock on June 16, 2026. The shares were sold at $5.67 per share, resulting in total proceeds of approximately $1,258.74. According to footnote F1, this transaction represents shares withheld to satisfy tax withholding obligations upon the vesting of restricted stock awards. Following this transaction, Vasanthavada holds 303,229 shares of common stock. The filing was signed by Joseph Vazzano as attorney-in-fact on June 17, 2026. This is a routine transaction related to tax obligations rather than a discretionary sale by the officer.